About ZYGOFIX

ZygoFix was founded by renowned orthopedic experts and enterpreneurs with a mission to transform joint stabilization and fusion for surgeons and patients.

We are dedicated to delivering safe, effective, and minimally invasive fixation solutions tailored for the rapidly growing Ambulatory Surgery Center (ASC) market.

Management  team

Ofer Levy | CE0

  • 20+ years experience in the medical device industry as an engineer, product manager, and consultant; deep understanding of medical device development and lifecycle; MBA, Tel Aviv University, B.Sc., mechanical engineering, Ben-Gurion University of the Negev​​

Uri Arnin | Co-Founder, CTO

  • Serial entrepreneur in the field of spinal implants; 30 years experience in the medical device industry; 29 issued patents and 43 pending (all in the spine); inventor of the TOPS system (world’s first facet replacement device - Premia Spine); CTO, Spine 21 (world’s first remote-controlled spinal implant); founder and CTO, ApiFix (Acquired by Orthopediatrics 04.2020)​​.

Maor Rozenberg | VP R&D

  • M.Sc Biomedical Engineering

    B.Sc Mechanical Engineering

    CTO and R&D Mechanical Leader in medical device startup companies

    More then 10 years of medical device R&D

Ofir Kahlon | QA RA Manager

  • Medical device Regulatory Affairs and Quality Management System Expert with over 5 years’ experience.

    Managed a number active, non-active and implant medical systems through CE certification, FDA clearance and ongoing compliance.

Board of Directors

Nicholas Pachuda | Chairman

  • Nick is seasoned Life Science leader combining his clinical, technical, and business experience to anticipate market trends, identify transformational opportunities, and accelerate their path to clinical and commercial success.  

    Previously, Nick led Global External Innovation for Johnson & Johnson’s Orthopedic Franchise.  Nick has created multiple new commercial ventures while at DePuy Synthes and Arthrex (Digital Surgery & Robotics, Ambulatory Surgery Centers, Sports Medicine, Extremities).  He has also developed and restructured startups for successful exits (SBI to Stryker, Scient’X to Alphatec).

    Nick is a graduate of the University of Pittsburgh and received his Doctor of Podiatric Medicine degree from the Pennsylvania School of Podiatric Medicine.  His surgical residency was at the University of Medicine and Dentistry of New Jersey.  He completed an Orthopedic Trauma Fellowship in Germany and went on to clinical practice for ten years, prior to joining industry in 2003. 

Barak Singer

  • Barak Singer has over 15 years of experience in management, business development, investment banking, and venture capital.

    Among others, Barak served as VP Business Development at Can-Fite BioPharma (NYSE: CANF) and CEO of its subsidiary Ophthalix, VP Business Development at Xenia Venture Capital, and was a Co-Founder and CEO at Or Capital Healthcare Partners.

    Barak currently serves as the CEO of Trendlines Israel Incubator.

Todd Dollinger

  • Founder & Chair Emeritus, The Trendlines Group

    Todd Dollinger brings more than four decades of wide-ranging marketing, sales, and entrepreneurial experience to Trendlines.

    He chairs the investment committees of Trendlines Investments Israel, our Singapore-based Trendlines Agrifood Innovation Centre, and the Trendlines Agrifood Fund. Additionally, Todd is a director and chairs several Trendlines’ portfolio companies. He also serves as a board member of the non-profit Davos-based AO Foundation’s Technology Board which, inter alia, is responsible for allocating Development Incubator funds.

    Todd founded The Trendlines Group with Steve Rhodes in 2007 and shares the position of Chair of Trendlines with Steve.

    In 1991, Todd joined the marketing department of Israeli medical device start-up SRD Medical Ltd. (“SRD”) and went on to become SRD’s CEO. It was at SRD that Todd and Steve met. In 1993, Todd and Steve founded Trendlines International Ltd. They merged the principal consulting activities of Trendlines International Ltd. into The Trendlines Group in 2008.

    Under the strength of their 30-year business partnership, Todd and Steve oversaw Trendlines’ IPO on the Singapore Stock Exchange in 2015; and have raised funds around the world for Trendlines, its venture funds, and portfolio companies. They have exited portfolio companies to multinational corporations; taken portfolio companies public; and have expanded the Group’s activities internationally.

Scientific Advisory Board

Jon Luedke

  • Over 20 years experience in the US medical device industry.  Successful commercialization and revenue generation at Zimmer Spine, Centinel Spine, Wenzel Spine, Prosidyan (exclusive rights were acquired by DePuy Synthes), and President & CEO of Spineway USA.

Ira Fedder MD

  • Doctor of pharmacy and MD graduate from the University of Maryland; Post graduate training in Orthopedic surgery at St. Joseph Medical Center.

Babak Barcohana MD

  • Neuroscience graduate from UCLA; MD graduate from UCSF; Residency trained in Orthopedic surgery at Standford University. Dr. Barcohana has specific expertise in minimal invasive surgical techniques.

Isador Lieberman MD

  • Renowned Orthopedic & Spine Surgeon with leadership roles at top US institutions and 40+ spinal surgery patents.